FTH
Faeth Therapeutics, Inc. SEC filings
Every EDGAR filing for Faeth Therapeutics, Inc. (FTH), newest first, with AI summaries and stories.
- Ticker
- FTH
- CIK
- 1829802
- Latest filing
- Sep 17
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
Filings
8-KFaeth Therapeutics, Inc.SNSELIVE 4Faeth Therapeutics, Inc.SNSELIVE 2 insider filings
Karen H Vousden, insider filing for SNSE
Show all 2
- 4Insider filing for SNSE
- 3New insider at SNSE
Karen H Vousden, reporting
SCHEDULE 13G/AFaeth Therapeutics, Inc.SNSELIVE 3 13G filings
Ownership stake disclosure by Caligan Partners LP (amended)
Show all 3
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13GOwnership stake disclosure
Caligan Partners LP, filed by
SCHEDULE 13G/AFaeth Therapeutics, Inc.SNSELIVE Ownership stake disclosure by STEMPOINT CAPITAL LP (amended)
STEMPOINT CAPITAL LP, filed by
144Faeth Therapeutics, Inc.SNSELIVE Cambrian BioPharma Inc, planned sale of SNSE shares
Cambrian BioPharma Inc, reporting
10-QFaeth Therapeutics, Inc.SNSELIVE 8-KFaeth Therapeutics, Inc.SNSELIVE 3Faeth Therapeutics, Inc.SNSELIVE Vinod Khosla, new insider at SNSE
Vinod Khosla, reporting · VK Services, LLC, reporting · +4 more
8-KFaeth Therapeutics, Inc.SNSELIVE 4Faeth Therapeutics, Inc.SNSELIVE 2 insider filings
Anand Kiran Parikh, insider filing for SNSE
Show all 2
- 4Insider filing for SNSE
- 4Insider filing for SNSE
Anand Kiran Parikh, reporting
4Faeth Therapeutics, Inc.SNSELIVE Brian C Stephenson, insider filing for SNSE
Brian C Stephenson, reporting
4Faeth Therapeutics, Inc.SNSELIVE Brian C Stephenson, insider filing for SNSE
Brian C Stephenson, reporting
4Faeth Therapeutics, Inc.SNSELIVE 2 insider filings
Brian C Stephenson, insider filing for SNSE
Show all 2
- 4Insider filing for SNSE
- 4Insider filing for SNSE
Brian C Stephenson, reporting
3Faeth Therapeutics, Inc.SNSELIVE Brian C Stephenson, new insider at SNSE
Brian C Stephenson, reporting
SCHEDULE 13GFaeth Therapeutics, Inc.SNSELIVE 2 13G filings
Ownership stake disclosure by SUVRETTA CAPITAL MANAGEMENT, LLC
Show all 2
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13GOwnership stake disclosure
SUVRETTA CAPITAL MANAGEMENT, LLC, filed by
8-KFaeth Therapeutics, Inc.SNSELIVE S-3ASRFaeth Therapeutics, Inc.SNSELIVE 4Sensei Biotherapeutics, Inc.SNSELIVE 6 insider filings
Saira Ramasastry, insider filing for SNSE
Show all 6
- 4Insider filing for SNSE
- 4Insider filing for SNSE
- 3New insider at SNSE
- 4Insider filing for SNSE
- 3New insider at SNSE
- 4/AInsider filing for SNSE (amended)
Saira Ramasastry, reporting
8-KSensei Biotherapeutics, Inc.SNSELIVE EFFECTSensei Biotherapeutics, Inc.SNSELIVE 4Sensei Biotherapeutics, Inc.SNSELIVE 3 insider filings
Christopher Gerry, insider filing for SNSE
Show all 3
- 4Insider filing for SNSE
- 4Insider filing for SNSE
- 4Insider filing for SNSE
Christopher Gerry, reporting
S-3/ASensei Biotherapeutics, Inc.SNSELIVE 8-KSensei Biotherapeutics, Inc.SNSELIVE SCHEDULE 13G/ASensei Biotherapeutics, Inc.SNSELIVE Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC (amended)
MILLENNIUM MANAGEMENT LLC, filed by
10-K/ASensei Biotherapeutics, Inc.SNSELIVE S-3/ASensei Biotherapeutics, Inc.SNSELIVE 4Sensei Biotherapeutics, Inc.SNSELIVE 2 insider filings
Cambrian BioPharma Inc, insider filing for SNSE
Show all 2
- 4Insider filing for SNSE
- 4Insider filing for SNSE
Cambrian BioPharma Inc, reporting
DEFA14ASensei Biotherapeutics, Inc.SNSELIVE 8-KSensei Biotherapeutics, Inc.SNSELIVE DEFA14ASensei Biotherapeutics, Inc.SNSELIVE 8-KSensei Biotherapeutics, Inc.SNSELIVE 4Sensei Biotherapeutics, Inc.SNSELIVE 4 insider filings
Israel A Englander, insider filing for SNSE
Show all 4
- 4Insider filing for SNSE
- 4Insider filing for SNSE
- 4Insider filing for SNSE
- 3New insider at SNSE
Israel A Englander, reporting · MILLENNIUM MANAGEMENT LLC, reporting · +2 more
SCHEDULE 13GSensei Biotherapeutics, Inc.SNSELIVE Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC
MILLENNIUM MANAGEMENT LLC, filed by